Star Combo Pharma Ltd (S66) — Cash Flow-to-Debt Ratio
Star Combo Pharma Ltd (S66) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2025, meaning its operating cash flow of AU$575.23K could theoretically repay 0% of its total liabilities (AU$8.30 Million) in one year. See Star Combo Pharma Ltd (S66) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Star Combo Pharma Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Star Combo Pharma Ltd across 10 annual periods. Also explore Star Combo Pharma Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Star Combo Pharma Ltd (2016–2025)
Year-by-year debt coverage analysis for Star Combo Pharma Ltd. For market capitalisation and broader financial context, see Star Combo Pharma Ltd (S66) total market value.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | AU$11.94 Million | AU$10.19 Million | ▲ +3546.3% |
| 2024 | -0.03x | AU$-316.45K | AU$9.30 Million | ▼ -116.3% |
| 2023 | 0.21x | AU$1.88 Million | AU$8.97 Million | ▲ +1831.2% |
| 2022 | 0.01x | AU$87.11K | AU$8.04 Million | ▼ -76.7% |
| 2021 | 0.05x | AU$331.53K | AU$7.13 Million | ▲ +146.7% |
| 2020 | -0.10x | AU$-1.02 Million | AU$10.22 Million | ▲ +65.8% |
| 2019 | -0.29x | AU$-2.19 Million | AU$7.51 Million | ▲ +56.0% |
| 2018 | -0.66x | AU$-1.84 Million | AU$2.78 Million | ▼ -358.1% |
| 2017 | 0.26x | AU$932.20K | AU$3.64 Million | ▼ -36.6% |
| 2016 | 0.40x | AU$1.30 Million | AU$3.21 Million | — |